German drugmaker Bayer said it filed for marketing approval in Europe for the use of eye drug Eylea as a treatment of diabetic macular oedema.
The IPAB ruling in favour of the Natco Pharma against Bayer has reignited the debate over innovation versus access in the health sector.
India`s decision to allow the production of a cheaper generic copy of a patented cancer drug will be challenged by German drug maker Bayer.
India`s move to strip German drugmaker Bayer of its exclusive rights to a cancer drug has set a precedent that could extend to other treatments.
Day in Pics: 5th March
Showbiz World - March 5 2015
Sofia Hayat celebrates Holi